Difference between revisions of "Albendazole"
Neil.m.young (talk | contribs) (Text replacement - "0 mg" to "0mg") |
Neil.m.young (talk | contribs) (Text replacement - "5 mg" to "5mg") |
||
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
*Microsporidiosis: 400mg po bid | *Microsporidiosis: 400mg po bid | ||
| − | *neurocysticerosis: < 60 kg: | + | *neurocysticerosis: < 60 kg: 15mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days |
==Pediatric Dosing== | ==Pediatric Dosing== | ||
| − | *neurocysticerosis: < 60 kg: | + | *neurocysticerosis: < 60 kg: 15mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days |
==Special Populations== | ==Special Populations== | ||
Revision as of 03:28, 19 July 2016
Contents
General
- Type: antiparasitic
- Dosage Forms: 200mg
- Common Trade Names:Albenza
Adult Dosing
- Microsporidiosis: 400mg po bid
- neurocysticerosis: < 60 kg: 15mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days
Pediatric Dosing
- neurocysticerosis: < 60 kg: 15mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days
Special Populations
- Pregnancy Rating:C
- Lactation: unknown
- Renal Dosing
- Adult: not defined
- Pediatric: not defined
- Hepatic Dosing
- Adult: not defined
- Pediatric: not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- leukopenia
- neutropenia
- pancytopenia
- acute renal failure
- hepatitis
- SJS
Common
- abnormal LFT's
- abdominal pain
- nausea/vomiting
- headache
- dizziness
- alopecia
- fever
Pharmacology
- Half-life: 8-12 hour
- Metabolism: liver
- Excretion: bile
- Mechanism of Action: inhibits tublin polymerization